New specialty pharmacy and infusion suite combines compassionate nursing and infusion expertise for patients managing ...
Raleigh-based Slate Medicines just pulled in a hefty $130 million Series A, a war chest the startup says will fuel development of SLTE‑1009, an in‑licensed anti‑PACAP monoclonal antibody aimed at ...
The biotech is developing a drug aimed at a protein called PACAP, which has emerged as a potentially new way to prevent the ...
Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes year-end report for 2025. The report is available on the company's website ( ...
Pegzilarginase is an enzyme replacement therapy that provides an exogenous source of the deficient human arginase 1 enzyme to reduce blood arginine levels.
Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing ...
NEW YORK – The European Commission on Monday approved Johnson & Johnson's subcutaneous Rybrevant (amivantamab) in two new dosing schedules as a first-line treatment for patients with advanced ...
What are bankers and analysts saying about concerns that an AI bubble could negatively impact credit markets? Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results